Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2012
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276098 Drug fusions and conjugates with extended half life
11/01/2012US20120276081 Body weight gain suppressing composition and food product comprising the same
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276070 Induced Pluripotent Stem Cells and Related Methods
11/01/2012US20120276067 Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276058 Methane reducing strains and methods of use
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834465A1 Cyclic amide derivative
11/01/2012CA2834429A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012CA2834417A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012CA2834232A1 Modulation of apolipoprotein ciii (apociii) expression
11/01/2012CA2834215A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
10/2012
10/31/2012EP2518072A1 Imidazopyridazine compounds
10/31/2012EP2518060A1 Novel 3-hydroxy-5-arylisothiazole derivative
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2517715A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof
10/31/2012EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
10/31/2012EP2516446A2 Substituted hexahydrochromeno[3,4-b]pyrroles with affinity for the serotonin receptor (5-ht) family
10/31/2012EP2515928A1 Oxyntomodulin peptide analogue
10/31/2012EP2515927A1 Oxyntomodulin peptide analogue
10/31/2012EP2515907A1 Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases
10/31/2012EP2515903A1 Compounds, preparations and uses thereof
10/31/2012EP2515901A2 Compositions and methods for treating obesity and diabetes
10/31/2012CN202505600U Novel traditional Chinese medicinal treatment sock for diabetic foot
10/31/2012CN1939532B Use of fungal immunomodulatory protein
10/31/2012CN102762731A Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
10/31/2012CN102762589A Insulin analogues with chlorinated amino acids
10/31/2012CN102762564A Ghrelin receptor agonist for treatment of dyscrasia
10/31/2012CN102762209A Pharmaceutical composition comprising metformin and rosuvastatin
10/31/2012CN102757880A Maca health-care wine and preparation method thereof
10/31/2012CN102757515A Method for extracting high-purity flavonoid and pectin from citrus peel
10/31/2012CN102757508A Application of ophiopogon polysaccharide extract in preparing foodstuff additives, health-care products or medicines with weight-reducing function
10/31/2012CN102757497A Anti-PEDF monoclonal antibody, and preparation method and application thereof
10/31/2012CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug
10/31/2012CN102757441A Furano[3,2-g]chromene compounds and applications thereof
10/31/2012CN102757420A Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound
10/31/2012CN102757415A Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
10/31/2012CN102757370A Derivatives of p-aminobenzoic acid and applications thereof
10/31/2012CN102757338A Fenofibric urethan, preparation method and application thereof
10/31/2012CN102757334A Sodium phenylbutyrate type II crystal and preparation method thereof
10/31/2012CN102757299A Protein tyrosine phosphatase inhibitor
10/31/2012CN102755648A Preparation method of anti-aging human universal nutritional supplement
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102755634A Nutrient composition
10/31/2012CN102755633A Application of human recombinant protein PDCD5 to treatment of autoimmune disease
10/31/2012CN102755568A Health-care product for assisting in decreasing blood sugar and preparation method thereof
10/31/2012CN102755561A Health care product used for diabetic fundus hemorrhage
10/31/2012CN102755530A Traditional Chinese medicine composition for treating diabetic foot and application thereof
10/31/2012CN102755523A Serine peptidase chrome chelating agent for anti-oxidation and anti-fatigue and preparation method thereof
10/31/2012CN102755460A Novel comprehensive marine medicated bath and implementation scheme
10/31/2012CN102755444A Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof
10/31/2012CN102755405A Fructus crataegi leaf water extract, preparation containing same and preparation method pf fructus crataegi leaf water extract
10/31/2012CN102755376A Preparing method of licorice
10/31/2012CN102755375A Deer heart blood soft capsule
10/31/2012CN102755374A Acceleration agent of calcium absorption
10/31/2012CN102755359A Hippophae extract and preparation method and application thereof for inhibiting activity of fatty acid synthase
10/31/2012CN102755348A Carbohydrate and electrolyte injection and preparation method thereof
10/31/2012CN102755347A Glucose electrolyte effervescent tablets and preparation method thereof
10/31/2012CN102755346A Compound polysaccharide formula of edible fungus as well as preparation method and application thereof
10/31/2012CN102755344A Quercetin medicine gastric-retention preparation
10/31/2012CN102755340A Blood sugar value depressant
10/31/2012CN102755334A Medicine composition of cycloartenyl ferulate
10/31/2012CN102755319A Pharmaceutical composition containing prasugrel and carvedilol, and purpose thereof
10/31/2012CN102755315A Application of ginkgoneolic acid in preparing medicines for treating immunological diseases
10/31/2012CN102755306A Application of hydroxytyrosol in medicine used for preventing and curing obesity
10/31/2012CN102755301A Glimepiride tablet and preparation method thereof
10/31/2012CN102755284A Fluvastatin sustained-release medicinal composition
10/31/2012CN102754831A Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar
10/31/2012CN102754824A Health food for relieving hyperlipemia
10/31/2012CN102754814A Blood pressure reduction sauce
10/31/2012CN102319262B 5% glucose child nutrient solution and preparation method thereof
10/31/2012CN102319259B 5% glucose adult nutrient solution and preparation method thereof
10/31/2012CN102319258B 5 percent glucose substitution liquid and preparation method thereof
10/31/2012CN102266368B Traditional Chinese medicine composition with functions of regulating blood lipid and delaying aging and manufacturing method thereof
10/31/2012CN102228539B Rosa davurica total flavone extract, its extracting method and its medical use
10/31/2012CN102206291B Process for extracting yam polysaccharide by using supercritical CO2 fluid extraction technique
10/31/2012CN102133273B Traditional Chinese medicine lipid-lowing and catharsis capsule and preparation method thereof
10/31/2012CN102106895B Composition with function of regulating blood fat
10/31/2012CN101896174B Trans-clomiphene for metabolic syndrome
10/31/2012CN101891618B 2-[(2,3,4-trialkoxy-6-acyl) phenyl] acetic ester as well as preparation method and application thereof
10/31/2012CN101736065B Method for preparing polypeptide by beer sediment
10/31/2012CN101723896B Tyrosine derivative histone deacetylases inhibitor and application thereof
10/31/2012CN101679317B Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor binding activity
10/31/2012CN101547902B pyridine derivatives for treatment of metabolic disorders related with insulin resistance and hyperglycemia
10/31/2012CN101426775B Oxadiazolidinedione compound
10/30/2012US8299064 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
10/30/2012US8299025 glucagon-like peptide-1; osmotic drug delivery device and method
10/30/2012CA2565293C Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
10/30/2012CA2456732C Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/26/2012WO2012145604A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145603A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012145523A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012WO2012145374A1 TARGETING miR-378 FAMILY MEMBERS FOR THE TREATMENT OF METABOLIC DISORDERS
10/26/2012WO2012144892A1 Medical use for acidic cannabinoids
10/26/2012WO2012144854A2 Novel uses of licochalcone a